Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > $1.45

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Jan 11, 2024 11:22am

322 Views

Post# 35821510

$1.45

One month ago Matt Coffey refused the option to purchase 175,000 shares of ONC at $1.45 CDN.

He knows more about ONC's prospects than any person on the planet.

And here we are, one month later, with a SP slippling slowly toward $1.45 CDN.

Matt is a wise man! He knew ONC was over-valued.

I wonder if he would exercise options with a strike price of $1.00 CDN and an expiry today?

NOT LIKELY!!

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!